share_log

Teladoc Health | 10-K: FY2023 Annual Report

SEC ·  Feb 23 15:15

Summary by Moomoo AI

Teladoc Health, a global leader in virtual healthcare, reported an 8% increase in total revenue, reaching $2.6 billion for the fiscal year ended December 31, 2023, compared to $2.4 billion in the previous year. The growth was primarily driven by an 8% rise in access fees, particularly from the BetterHelp segment, and a 6% increase in other revenues, notably from telehealth solutions for hospitals and health systems. U.S. revenue grew by 6%, while international revenue saw a 19% increase. Despite the revenue growth, the company experienced a net loss of $220.4 million, a significant improvement from the previous year's net loss of $13.7 billion, which included a substantial goodwill impairment charge. The adjusted EBITDA increased by 33% to $328.1 million. Teladoc Health's Integrated Care segment saw a 7% revenue increase to...Show More
Teladoc Health, a global leader in virtual healthcare, reported an 8% increase in total revenue, reaching $2.6 billion for the fiscal year ended December 31, 2023, compared to $2.4 billion in the previous year. The growth was primarily driven by an 8% rise in access fees, particularly from the BetterHelp segment, and a 6% increase in other revenues, notably from telehealth solutions for hospitals and health systems. U.S. revenue grew by 6%, while international revenue saw a 19% increase. Despite the revenue growth, the company experienced a net loss of $220.4 million, a significant improvement from the previous year's net loss of $13.7 billion, which included a substantial goodwill impairment charge. The adjusted EBITDA increased by 33% to $328.1 million. Teladoc Health's Integrated Care segment saw a 7% revenue increase to $1.47 billion, with adjusted EBITDA up by 42% to $191.9 million. The BetterHelp segment's revenue grew by 11% to $1.13 billion, with adjusted EBITDA rising by 19% to $136.2 million. The company's cash flow from operating activities improved, with a $160.7 million increase to $350 million, and free cash flow jumped to $193.7 million from $16.5 million in the previous year. Teladoc Health's future plans include a focus on balanced growth and efficiency, with a comprehensive operational review underway to drive further efficiencies and support growth. The company expects to incur restructuring costs in the year ending December 31, 2024, as part of these efforts.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more